机器人辅助脑干出血微创手术 (RAINBOW-BSH)
机器人辅助脑干出血微创手术策略研究
The purpose of this clinical trial is to observe the improvements in clinical symptoms and imaging outcomes for brainstem hemorrhage using robot-assisted stereotactic puncture, evaluate the clinical efficacy and safety of this treatment, and explore the development of a high-precision, intelligent, and individualized microsurgical diagnosis and treatment process for brainstem hemorrhage. The main questions it aims to address are:
- Establish a multi-center clinical database for brainstem hemorrhage.
- Clinically observe and evaluate the intervention effects of robot-assisted stereotactic puncture on brainstem hemorrhage, compare it with the traditional conservative treatment control group, and investigate its efficacy and impact on patient survival, motor evoked potentials, and the degree of neurological deficits.
- Optimize the Artificial Intelligence (AI) algorithm-based robotic surgical assistance system, and explore the prediction of preoperative brainstem hematoma stability and hematoma path planning.
Participants in the experimental group will:
- Undergo robot-assisted stereotactic minimally invasive surgery for brainstem hematoma puncture
- Receive conservative non-surgical treatment.
If there is a control group: the researchers will compare the conservative non-surgical treatment group to evaluate the effectiveness of robot-assisted stereotactic minimally invasive surgery for brainstem hematoma puncture.
研究概览
地位
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Yanbing Yu, M.D.
- 电话号码:+86-13901114963
- 邮箱:yuyanbing123@126.com
研究联系人备份
- 姓名:Yulian Zhang, M.D.
- 电话号码:+86-13051581507
- 邮箱:398824625@qq.com
学习地点
-
-
Beijing Municipality
-
Beijing、Beijing Municipality、中国、100029
- 招聘中
- China-Japan Friendship Hospital
-
接触:
- Yulian Zhang, M.D.
- 电话号码:+86-13051581507
- 邮箱:398824625@qq.com
-
接触:
- Yanbing Yu, M.D.
- 电话号码:13901114963
- 邮箱:yuyanbing123@126.com
-
副研究员:
- Xu Yang, M.D.
-
Beijing、Beijing Municipality、中国、100049
- 招聘中
- Aerospace Center Hospital
-
接触:
- Feng Yin, M.D.
- 电话号码:+86-13381207600
- 邮箱:yinf897@163.com
-
接触:
- Hui Chen, M.D.
- 电话号码:+86-13810520648
- 邮箱:16564583@qq.com
-
-
Guangxi
-
Nanning、Guangxi、中国、530021
- 招聘中
- The First Affiliated Hospital of Guangxi Medical University
-
接触:
- DAQIN FENG
- 电话号码:+8619914884494
- 邮箱:13807713918@163.com
-
-
Hebei
-
Shijiazhuang、Hebei、中国、100190
- 招聘中
- Hebei Provincial People's Hospital
-
接触:
- Tao Qian, M.D.
- 电话号码:+86-15931423666
- 邮箱:qt1966a@163.com
-
接触:
- Yang Li, M.D.
- 电话号码:+86-18632109423
- 邮箱:772355464@qq.com
-
-
Jiangsu
-
Nanjing、Jiangsu、中国、210008
- 招聘中
- Nanjing Drum Tower Hospital
-
接触:
- CHUNHUA HANG
- 电话号码:+8613813379309
- 邮箱:hang1965@nju.edu.cn
-
Nantong、Jiangsu、中国、226001
- 招聘中
- Affiliated Hospital of Nantong University
-
接触:
- JIANHONG SHEN
- 电话号码:+8613506287516
- 邮箱:tysjh@163.com
-
-
Jiangxi
-
Nanchang、Jiangxi、中国、330006
- 招聘中
- The Second Affiliated Hospital of Nanchang University
-
接触:
- HUA GUO
- 电话号码:+8613697081718
- 邮箱:ndefy02014@ncu.edu.cn
-
-
Shanghai Municipality
-
Shanghai、Shanghai Municipality、中国、200040
- 招聘中
- Huashan Hospital Fudan University
-
接触:
- JIN HU
- 电话号码:+8618930174565
- 邮箱:hujin@fudan.edu.cn
-
Shanghai、Shanghai Municipality、中国、201199
- 招聘中
- Shanghai Minhang District Central Hospital
-
接触:
- FULIN XU
- 电话号码:+8618121270156
- 邮箱:18918169183@163.com
-
Shanghai、Shanghai Municipality、中国、200120
- 招聘中
- Shanghai East Hospital, Tongji University
-
接触:
- CHUNLONG ZHONG
- 电话号码:+8613917920669
- 邮箱:drchunlongzhong@tongji.edu.cn
-
Shanghai、Shanghai Municipality、中国、201508
- 招聘中
- Jinshan Hospital, Fudan University
-
接触:
- ERSONG WANG
- 电话号码:wersong@aliyun +8618930815670
-
-
Tianjin Municipality
-
Tianjin、Tianjin Municipality、中国、300350
- 招聘中
- Tianjin Huanhu Hospital
-
接触:
- JIE ZUO
- 电话号码:+8618920195507
- 邮箱:luckywhg@163.com
-
-
Zhejiang
-
Hangzhou、Zhejiang、中国、310009
- 招聘中
- The Second Affiliated Hospital of Zhejiang University School of Medicine
-
接触:
- Gao Chen
- 电话号码:+8613738194475
- 邮箱:d-chengao@zju.edu.cn
-
Jinhua、Zhejiang、中国、321000
- 招聘中
- Jinhua Municipal Central Hospital / Jinhua Hospital Affiliated to Zhejiang University School of Medicine
-
接触:
- MINFENG TONG
- 电话号码:+8613646694178
- 邮箱:Tmfhyj@sina.com
-
Wenzhou、Zhejiang、中国、325000
- 招聘中
- The First Affiliated Hospital of Wenzhou Medical University
-
接触:
- QUN LI
- 电话号码:+8615858002900
- 邮箱:garylina@126.com
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Participants must meet all of the following inclusion criteria:
- Age ≥18 years at randomization;
- Diagnosed with brainstem hemorrhage via imaging (CT, CTA, etc.);
- Hematoma volume ≥3 mL;
- Glasgow Coma Scale (GCS) score of 3-12;
- Available for surgery within 48 hours after onset;
- Modified Rankin Scale (mRS) score ≤ 1 prior to this hemorrhage;
- Informed consent obtained in accordance with national laws, regulations, and applicable ethics committee requirements.
Patients will be excluded if they meet any of the following criteria:
- Hematoma involving other regions such as the supratentorial compartment, basal ganglia, thalamus, midbrain, or ventricles.
- Radiologically confirmed cerebral vascular abnormalities including ruptured aneurysms, arteriovenous malformations (AVMs), or Moyamoya disease; hemorrhagic transformation of ischemic infarcts; or recent (within 1 year) recurrence of intracerebral hemorrhage;
- Any irreversible coagulation disorder or known coagulopathy; platelet count <100,000/µL; INR >1.4; or use of anticoagulant medication within 7 days before the current hemorrhage;
- Current or probable pregnancy;
- Patients with concurrent severe illness likely to influence outcome assessment;
- Difficulty in follow-up or poor compliance due to any cause.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Robot-assisted minimally invasive puncture and aspiration surgery
The intervention group will receive robot-assisted stereotactic puncture for brainstem hemorrhage |
Positioning and surgical operation will be performed according to the robot navigation system protocols. Preoperative imaging data will be used for precise surgical planning, including the construction of a three-dimensional (3D) preoperative visualization model. The 3D reconstruction and CT data will be imported into the AI robot-assisted stereotactic system, which, after mapping to the patient's skull, automatically designs the surgical target, calculates coordinate values, plans the puncture trajectory, and determines the cranial entry point. Different surgical approaches will be selected based on the location and shape of the hematoma, and individualized parameters, including puncture direction and trajectory length, will be generated for each patient. During the procedure, the robot will assist with stereotactic puncture, while the patient's heart rate and blood pressure are closely monitored.
其他名称:
According to the "Chinese Neurosurgical Expert Consensus on the Diagnosis and Treatment of Primary Brainstem Hemorrhage", conventional medical treatment includes oxygen therapy, specialized nursing care, blood pressure control (maintaining BP at ≤140/90 mmHg), sedation, intracranial pressure reduction, arousal promotion, gastric protection, maintenance of internal homeostasis, infection prevention, neuro-nutrition, brain function support, nutritional support, and overall systemic management; For comatose patients, ensure a patent airway, provide nebulization and sputum clearance, prevent respiratory depression, and improve respiratory function. Closely monitor the patient's condition and provide active symptomatic treatment as needed. Regular cranial CT scans are performed to evaluate intracranial status, and in cases of ventricular hemorrhage or obstructive hydrocephalus, lateral ventricular puncture and drainage may be performed.
其他名称:
|
|
有源比较器:Standard medical management
The control group will undergo conventional medical conservative management. |
According to the "Chinese Neurosurgical Expert Consensus on the Diagnosis and Treatment of Primary Brainstem Hemorrhage", conventional medical treatment includes oxygen therapy, specialized nursing care, blood pressure control (maintaining BP at ≤140/90 mmHg), sedation, intracranial pressure reduction, arousal promotion, gastric protection, maintenance of internal homeostasis, infection prevention, neuro-nutrition, brain function support, nutritional support, and overall systemic management; For comatose patients, ensure a patent airway, provide nebulization and sputum clearance, prevent respiratory depression, and improve respiratory function. Closely monitor the patient's condition and provide active symptomatic treatment as needed. Regular cranial CT scans are performed to evaluate intracranial status, and in cases of ventricular hemorrhage or obstructive hydrocephalus, lateral ventricular puncture and drainage may be performed.
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Survival rate
大体时间:60 days
|
60 days survival rate after follow-up |
60 days
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Ordinal shift in mRS scores at 60 days and 6 months
大体时间:60 days and 6 months
|
The modified Rankin Scale (mRS) is a standardized tool used to assess the neurological recovery status of stroke patients. The scale is divided into seven levels, ranging from 0 to 6. Higher scores indicate more severe patient conditions. |
60 days and 6 months
|
|
Favorable functional outcome at 60 days and 6 months (mRS 0-1)
大体时间:60 days and 6 months
|
The modified Rankin Scale (mRS) is a standardized tool used to assess the neurological recovery status of stroke patients. The scale is divided into seven levels, ranging from 0 to 6. Higher scores indicate more severe patient conditions. |
60 days and 6 months
|
|
Functional independence at 60 days and 6 months (mRS 0-2)
大体时间:60 days and 6 months
|
The modified Rankin Scale (mRS) is a standardized tool used to assess the neurological recovery status of stroke patients. The scale is divided into seven levels, ranging from 0 to 6. Higher scores indicate more severe patient conditions. |
60 days and 6 months
|
|
Health-related quality of life (HRQoL) at 60 days and 6 months, assessed by the EQ-5D-5L questionnaire
大体时间:60 days and 6 months
|
Health-related quality of life (HRQoL) at 60 days and 6 months, assessed by the EQ-5D-5L questionnaire |
60 days and 6 months
|
|
Utility-weighted mRS at 60 days and 6 months
大体时间:60 days and 6 months
|
The modified Rankin Scale (mRS) is a standardized tool used to assess the neurological recovery status of stroke patients. The scale is divided into seven levels, ranging from 0 to 6. Higher scores indicate more severe patient conditions. |
60 days and 6 months
|
|
Cognitive function at 60 days and 6 months
大体时间:60 days and 6 months
|
Cognitive function at 60 days and 6 months |
60 days and 6 months
|
|
Total length of hospital stay
大体时间:60 days
|
Total length of hospital stay |
60 days
|
|
Costs during hospitalization
大体时间:60 days
|
Costs during hospitalization |
60 days
|
|
ICU length of stay
大体时间:60 days
|
ICU length of stay |
60 days
|
|
Brainstem hematoma clearance rate on postoperative days 1, 3, and 7
大体时间:1, 3, and 7 days
|
The change in hematoma volume compared to the preoperative CT scan was assessed 1, 3, and 7 days postoperatively. |
1, 3, and 7 days
|
|
Incidence of related complications within 14 days, including pneumonia, aphasia, seizures, and lower-extremity deep vein thrombosis
大体时间:14 days
|
Incidence of related complications within 14 days, including pneumonia, aphasia, seizures, and lower-extremity deep vein thrombosis |
14 days
|
合作者和调查者
赞助
调查人员
- 学习椅:Yanbing Yu, M.D.、China-Japan Friendship Hospital
出版物和有用的链接
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.